Verseon

United States
Clintonville, Wisconsin, United States, CA 94539

Company profile

Verseon company profile

Verseon is a technology-based pharmaceutical company developing novel therapeutics for today’s challenging diseases. The company’s proprietary drug discovery platform is the first systematic, computationally-driven solution to achieve the molecular modeling accuracy necessary for rapid and cost-effective drug discovery. Verseon plans to use its platform to establish a diversified discovery pipeline across multiple disease areas. It was founded in 2002 and is headquartered in Fremont, California.

Business identity

Contact email
[email protected]
Phone number
+1 510 225 9000
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$0+
Founded
2002-01-01, Year

Headquarters

Postal code
CA 94539
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
7
Total equity funding
$124.8M
Last funding
Post IPO Equity / $11.8M / 2019-09-16
Last equity funding
Post IPO Equity / $11.8M
Investors
2
Founders
3
Articles
19
Exited on
2015-05-08

Founders and investors

Founders

Adityo PrakashDavid KitaEniko Fodor

Investors

John LeonardRobert Karr